SEC Form D filing

AOA DX Inc., 2025-10-15

An SEC Form D private-offering notice from Denver, CO, a $30,582,903 filer-stated offering target in Biotech. Filed 2025-10-15. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

AOA DX Inc. site↗ Verified via SEC Form D

AI powered blood test platform for early detection of ovarian cancer using a proprietary multi omic biomarker technology called GlycoLocate.

Filed 2025-10-15Filed to raise $30,582,903First money in 2025-10-01Raised so far $8,085,364HQ (as filed) Denver, COSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aoadx.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in Colorado →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source